eLetters

218 e-Letters

published between 2003 and 2006

  • The return of silent ischemia? Not really
    Sakir Uen

    Dear Editor,

    Mulcahy's article is an interesting update on the subject of silent myocardial ischemia.[1] He postulates that ambulatory ST segment monitoring does not add significantly to the finding of exercise testing, because it would occur almost exclusively in patients with a positive result in the ischemia exercise test.

    In a German multicentre study, we have analyzed both exercise test and ambulat...

    Show More
  • Treatment of ST elevation myocardial infarction with primary angioplasty
    Dr Shamsul A Bhuiyan

    Dear Editor,

    We have read the article[1] with great interest. Selection of the 23 patients is not clearly mentioned here. There is a lack of some other information too. Once the chest pain started, after what time those patients were selected for angioplasty? What was the percentage of lumen narrowing or stenosis? Was the stenosis complicated or not? What was the material used for primary angioplasty?

    Rap...

    Show More
  • Time to treatment of acute ST elevation myocardial infarction
    Dr Shamsul A Bhuiyan

    Dear Editor,

    Intra-country variation versus inter-country variation in pre-hospital care management of acute MI with ST elevation is worrisome matter. Thanks to R C Welsh et al. for wring the article. ST elevation acute MI needs early treatment with fibrinolysis therapy as early possible.

    Study[1] shows that time management is the key of ST elevation MI. Rapid time to treatment with thrombolytic therapy...

    Show More
  • Representative of UK practice?
    Tom Quinn

    Dear Editor,

    The data presented in Welsh et al.'s paper assessing variations in practice across the 12 countries in the ASSENT 3 PLUS trial may not be representative of UK practice since each of the four constituent countries of the UK have distinct health systems.

    In England and Wales, both of which have national standards for the care of STEMI patients -National Service Frameworks- and in which all 130...

    Show More
  • Saving lives
    Jill F Pattenden

    Dear Editor,

    Norris[1] reports that most out of hospital cardiac arrest occurs in the home, but that as patients usually have premonitory symptoms, there is an opening for education about these symptoms and how to act to avoid delay and subsequent mortality. Although there is clearly a need to educate the public at large to call an ambulance if they witness what could be a heart attack or cardiac arrest, less is k...

    Show More
  • Intra-country variation in pre-hospital STEMI care
    Robert C. Welsh

    Dear Editor,

    We thank Dr Tom Quinn for his interest in this manuscript. His letter addresses the realities of intra-country variation versus inter-country variation in pre-hospital care. Dr Quinn appropriately points out in his letter to the editor that the United Kingdom is made up of distinct nations with distinct health systems. We have recognized this issue in the manuscripts limitations section, “Because our stu...

    Show More
  • New definition of an abnormal Q wave – is it clinically useful?
    Jesper Khédri Jensen

    Dear Editor

    Since myocardial infarction (MI) was redefined five years ago(1), focus has been on troponins. However, with the consensus document the presence of an abnormal Q wave has also been redefined, but this change appears to have created only little controversy. Abnormal Q waves are still considered a definite objective sign of an established MI, and in this connection, the history of the patient is often in...

    Show More
  • Glyceryl trinitrate, headache and coronary artery disease: mechanistic and therapeutic uncertainties
    Vinod K Gupta

    Dear Ediutor

    Hsi et al. propose absence or presence of gyceryl trinitrate (GTN)- induced headache as a possibly useful clinical tool to assist in the initial risk stratification of patients with chest pain [1]. Several issues merit attention:

    1. The mechanism of action of GTN in precipitation of headache in patients – regardless of status of the coronary circulation – is unknown.

    2. Exc...

    Show More
  • PFO and migraine: pearls and pitfalls in the theorizing process
    Vinod K Gupta

    Dear Editor,

    Wilmshurst et al.,[1] link inheritance of atrial shunts to inheritance of migraine with aura in some families. The link between migraine with aura and patent foramen ovale (PFO) appears to be gathering strength and the plea for randomized controlled trials of PFO-closure in migraine patients are beginning to appear justified.[2-4] The conclusion that closure of atrial shunts usually improves or cures...

    Show More
  • Hypertrophic cardiomyopathy showing its benign face
    Edmundo Arteaga

    Dear Editor,

    In patients with hypertrophic cardiomyopathy (HC) followed in our institution[1], the annual mortality rate was 1%, unexpectedly low for a selected cohort of patients with HC. Now, in view of the excellent recent article of Elliot et al.[2], in which they presented and discussed survival rates in HC, we are happy with the confirmation that even selected patients with HC may survive at high rates when...

    Show More

Pages